24 related articles for article (PubMed ID: 20032426)
1. Observational analysis of clinical and pathological characteristics and their prognostic impact in Mexican patients with breast cancer: A multi-center study.
Gozalishvilli-Boncheva A; Gonzalez-Espinoza IR; Castro-Ponce A; Bravo-Gutiérrez OA; Juárez-Salazar G; Montes-de-Oca-Moreda RI; Aguirre-Flores E; Coyotl-Huexotl M; Orozco-Luis J; Chiquillo-Domínguez M; Garibay-Díaz JC; Aranda-Claussen JE; Ponce-de-León EA; Sánchez-Sosa S; Sabaté-Fernández M; García-Reyna JC; Cordero-Vargas C; González-Blanco MJ; Aguilar-Priego JM; Sánchez-Fernández NJ; Cortés-García CA; González-Lozada LE; Miguel-Cruz E; Ceja-Utrera FJ; Hernández-Garcia MS; Piña-Vazquez M; Aguilar-Jiménez C
Breast Dis; 2023; 42(1):305-313. PubMed ID: 37807773
[TBL] [Abstract][Full Text] [Related]
2. CORRELATIONSHIP OF HORMONE RECEPTOR STATUS, p53 MUTATION AND c-erb B-2 OVEREXPRESSION WITH NUCLEAR GRADING IN BREAST CANCERS.
Deb P; Deshpande GU; Rai R
Med J Armed Forces India; 2000 Oct; 56(4):305-308. PubMed ID: 28790748
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of molecular classification of breast invasive ductal carcinoma.
Muñoz M; Fernández-Aceñero MJ; Martín S; Schneider J
Arch Gynecol Obstet; 2009 Jul; 280(1):43-8. PubMed ID: 19082617
[TBL] [Abstract][Full Text] [Related]
4. [Clinical characteristics and prognosis of breast cancer patients with vascular invasion].
Zhao WH; Xu BH; Zhang P; Li Q; Zhao LM; Sun Y
Zhonghua Zhong Liu Za Zhi; 2007 Feb; 29(2):137-40. PubMed ID: 17645853
[TBL] [Abstract][Full Text] [Related]
5. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
6. Immunohistochemical identification of basal-type cytokeratins in invasive ductal breast carcinoma--relation with grade, stage, estrogen receptor and HER2.
Kusińska R; Potemski P; Jesionek-Kupnicka D; Kordek R
Pol J Pathol; 2005; 56(3):107-10. PubMed ID: 16334976
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical tumor markers in infiltrating ductal breast carcinoma].
Gallegos M; González S; León A; Claure R; Goñi I; Andrade L; Duarte I
Rev Med Chil; 1998 Oct; 126(10):1216-23. PubMed ID: 10030093
[TBL] [Abstract][Full Text] [Related]
8. Utility of a simplified molecular classification of tumors for predicting survival of patients with invasive ductal breast carcinoma.
Muñoz-Díaz MM; Fernández-Aceñero MJ; Salvadores P; Schneider J
Anticancer Res; 2009 Nov; 29(11):4727-30. PubMed ID: 20032426
[TBL] [Abstract][Full Text] [Related]
9. Molecular classification of breast cancer: is it time to pack up our microscopes?
Cummings MC; Chambers R; Simpson PT; Lakhani SR
Pathology; 2011 Jan; 43(1):1-8. PubMed ID: 21240058
[TBL] [Abstract][Full Text] [Related]
10. [Diagnostic approach for breast cancer classification].
Penault-Llorca F; Mishellany F; Fouilhoux G; Trechot I; Maury F; Robin N; Cayre A; Dauplat MM
Rev Prat; 2013 Dec; 63(10):1384-90. PubMed ID: 24579333
[TBL] [Abstract][Full Text] [Related]
11. [New trends in diagnostics and classification of breast carcinoma].
Ryska A; Laco J; Hornychová H; Hornychová E; Melichar B
Cesk Patol; 2009 Apr; 45(2):29-34. PubMed ID: 19534390
[TBL] [Abstract][Full Text] [Related]
12. Scope and significance of non-uniform classification practices in breast cancer with non-inflammatory skin involvement: a clinicopathologic study and an international survey.
Güth U; Singer G; Schötzau A; Langer I; Dieterich H; Rochlitz C; Herberich L; Holzgreve W; Wight E
Ann Oncol; 2005 Oct; 16(10):1618-23. PubMed ID: 16033873
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
